Medicine and Dentistry
Pediatrics
100%
Neoplasm
92%
Childhood Cancer
79%
Malignant Neoplasm
63%
Acute Lymphoblastic Leukemia
53%
Ganglioglioma
35%
Ganglioneuroblastoma
32%
Pediatrics Patient
31%
Overall Survival
30%
Acute Myeloid Leukemia
29%
Wilms' Tumor
28%
Disease
27%
Pediatric Acute Myeloid Leukemia
24%
Diagnosis
23%
Event Free Survival
23%
Chemotherapy
22%
Systematic Review
21%
Immunotherapy
21%
Tumor
20%
Oncology
20%
Kidney Tumour
19%
Melanoma
19%
Hematopoietic Stem Cell Transplantation
19%
Hematopoietic Cell
19%
Biological Marker
18%
Central Nervous System Tumor
16%
Minimal Residual Disease
16%
Pediatric Cancer
16%
T Cell
16%
Clinical Trial
16%
Adolescence
16%
Quality of Life
16%
Leukemia
15%
B Cell
14%
Recurrent Disease
14%
Hazard Ratio
13%
Cell Transplantation
13%
Cancer
12%
Targeted Therapy
11%
Pheochromocytoma
11%
Magnetic Resonance Imaging
11%
Glioblastoma
11%
Dexamethasone
11%
Survival Rate
10%
Precursor
10%
Paraganglioma
10%
Central Nervous System
10%
RNA Sequence
10%
Retrospective Study
9%
Cohort Analysis
9%
Prognostic Factor
9%
Risk Stratification
9%
Organoid
9%
Radiation Therapy
9%
Soft Tissue Sarcoma
9%
Diseases
9%
Medicine
9%
Osteosarcoma
9%
COVID-19
8%
Rhabdomyosarcoma
8%
Odds Ratio
8%
Meta-Analysis
8%
Cancer Treatment
8%
Immunohistochemistry
8%
Cancer Therapy
7%
Tumor Cell
7%
Prevalence
7%
Randomized Controlled Trial
7%
Medulloblastoma
7%
Metachromatic Leukodystrophy
7%
DNA Methylation
7%
Adverse Event
7%
Metastatic Carcinoma
7%
Histopathology
6%
Immunity
6%
Gene Expression
6%
Acute Myelogenous Leukemia
6%
Cumulative Incidence
6%
Adjuvant Therapy
6%
Proportional Hazards Model
6%
High Risk Population
6%
Neuro-Oncology
6%
Pontine Glioma
6%
Progression Free Survival
6%
Prospective Study
6%
Cross Sectional Study
6%
Vincristine
6%
Germ Cell
6%
Methylation
6%
Arm
6%
Gene Fusion
6%
Radiation Therapy
5%
In Vitro
5%
Supportive Care
5%
Pembrolizumab
5%
Cord Blood Stem Cell Transplantation
5%
Clear Cell Renal Cell Carcinoma
5%
Transplantation
5%
Sarcopenia
5%
Patient Referral
5%
Keyphrases
Tumor
62%
Dutch
51%
Pediatric
38%
Acute Lymphoblastic Leukemia
37%
Pediatric Patients
33%
Childhood Cancer Survivors
27%
Pediatric Leukemia
27%
Overall Survival
26%
Wilms Tumor
26%
Neuroblastoma
24%
High Risk
24%
Acute Myeloid Leukemia
23%
Childhood Cancer
23%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
22%
Netherlands
20%
Event-free Survival
20%
Pediatric Oncology
19%
Children with Cancer
18%
Confidence Interval
17%
Older Adults
17%
Pediatric Acute Lymphoblastic Leukemia
16%
Graft-versus-host Disease (GvHD)
16%
Health-related Quality of Life
15%
Working Diagnosis
15%
Survivors
15%
Hematopoietic Cell Transplantation
14%
Hematopoietic Stem Cell Transplantation
14%
Minimal Residual Disease
14%
Childhood Acute Lymphoblastic Leukemia
14%
Risk Factors
14%
Chemotherapy
14%
Childhood Cancer Survivor Study
13%
Oncology
13%
Central Nervous System Tumors
13%
Glioma
13%
Glioblastoma
13%
Pediatric Cancer Patients
13%
T Cells
12%
Tumor Subtype
12%
Pheochromocytoma
12%
Melanoma
12%
Diffuse Intrinsic Pontine Glioma
11%
Paraganglioma
11%
Radiotherapy
11%
Cancer Treatment
10%
Meta-analysis
10%
Clinical Outcomes
10%
Diffuse Glioma
10%
Clinical Practice Guidelines
10%
Pediatric Cancer
10%
Hazard Ratio
10%
Relapsed or Refractory
9%
Cancer Types
9%
Relapsed or Refractory Acute Myeloid Leukemia
9%
BCP-ALL
9%
Renal Tumor
9%
Survival Rate
9%
High-risk Neuroblastoma
9%
Prognostic Factors
9%
Leukemia Patients
9%
Odds Ratio
9%
Leukemia
8%
RNA Sequencing (RNA-seq)
8%
Newly Diagnosed
8%
Phase II Trial
8%
Clinical Trials
8%
Randomized Controlled Trial
8%
Cancer Genome Atlas
8%
Antithymocyte Globulin
7%
IKZF1 Deletion
7%
Risk Stratification
7%
Improved Outcomes
7%
Pediatric Renal Tumors
7%
Pediatric Tumors
7%
Molecular Characterization
7%
Relapse Risk
7%
Molecular Analysis
7%
Adjuvant Therapy
7%
Isocitrate Dehydrogenase 1 (IDH1)
6%
Pharmacokinetics
6%
COVID-19 Pandemic
6%
Tumor Research
6%
Medulloblastoma
6%
Consensus Statement
6%
Late Effects
6%
Phase II Study
6%
Healthcare Professionals
6%
In Cancer
6%
Targeted Therapy
6%
Systematic Meta-analysis
6%
Treatment Outcome
6%
European Organizations
6%
International Consensus
6%
Renal Cell Carcinoma
6%
Oncology Studies
6%
Immunohistochemistry
6%
Sarcopenia
6%
Immune Reconstitution
5%
Magnetic Resonance Imaging
5%
Malignancy
5%